Publications, Pharmaceutical

In Vitro Anatomical Models for Nasal Drug Delivery

COVID-19 has stimulated interest in the use of nasal drug delivery for vaccines and anti-viral prophylactics, but the route also holds promise for treating disorders of the CNS.

This paper discusses the use of nasal casts, replicas of the human nasal cavity, for in vitro testing to improve our understanding of nasal drug delivery and more specifically to target deposition for optimal pharmacokinetic effect. The anatomy of the nose is discussed with reference to its impact on drug delivery and the evolution of nasal casts is reviewed. The application of nasal casts in vitro is examined along with strategies for validating performance against in vivo behavior. It is concluded that although nasal casts have certain well-recognized shortcomings, they are a useful tool for nasal drug delivery studies, for formulation and device optimization, targeted drug delivery and generic product development.

Download Publication on In Vitro Anatomical Models for Nasal Drug Delivery
Author(s): Julie D. Suman Gerallt Williams
26 Jun 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

16 Sep 2021

Introducing PureHale® for targeted upper respiratory tract care

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
9 Sep 2021

Aptar Pharma talks targeted drug delivery to the upper airways

Publications, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
17 Jun 2021

Drug Repurposing: A More Efficient Approach to Drug Development?

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Market Insights, Product Solutions

Read More
17 Jun 2021

Nasal Vaccination: Promises and Challenges

Webinars, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
1 16 17 18 19 20 27
Back To Top